Accesswire 16-Feb-2017 6:05 PM
IRVINE, CA / ACCESSWIRE / February 16, 2017 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA). Investors, who purchased or otherwise acquired shares between August 5, 2015 and October 21, 2016 inclusive (the "Class Period"), are encouraged to contact the firm in advance of the April 3, 2017 lead plaintiff motion deadline.
If you purchased shares of DaVita during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at email@example.com.
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
On January 6, 2017, the Wall Street Journal announced DaVita had received subpoenas from federal prosecutors for "the production of information related to charitable premium assistance" concerning the Company's relationship with the American Kidney Fund, a charity that offers financial help for patients undergoing kidney dialysis. When this information was released to the public, the value of DaVita stock fell, causing investors harm.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at firstname.lastname@example.org.
This press release may constitute Attorney Advertising in some jurisdictions.
Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 email@example.com
SOURCE: Khang & Khang LLP
Limited Time Offer:
Claim your free copy of income expert Bryan Perry's new report:
My Top Monthly Dividend Payer (8% Dividend Yield)
You'll also receive Bryan Perry's weekly e-letter, Dividend Investing Weekly, at no cost, along with other associated financial content and special offers.